Keryx Biopharmaceuticals, Inc. et al v. PAR Pharmaceutical, Inc.
| Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc. |
| PAR Pharmaceutical, Inc. |
| 1:2019cv04876 |
| May 24, 2019 |
| US District Court for the Southern District of New York |
| Edgardo Ramos |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 28, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (pne) |
| Filing 8 ELECTRONIC SUMMONS ISSUED as to PAR Pharmaceutical, Inc.. (pne) |
| Magistrate Judge Debra C. Freeman is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #http://nysd.uscourts.gov/forms.php. (pne) |
| Case Designated ECF. (pne) |
| Case Eligible for Patent Pilot Program. (pne) |
| CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Edgardo Ramos. Please download and review the Individual Practices of the assigned District Judge, located at #http://nysd.uscourts.gov/judges/District. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #http://nysd.uscourts.gov/ecf_filing.php. (pne) |
| Filing 7 NOTICE OF APPEARANCE by Timothy Andrew Cook on behalf of Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Cook, Timothy) |
| Filing 6 AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Gunther, Robert) |
| Filing 5 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Panion & BF Biotech, Inc..(Gunther, Robert) |
| Filing 4 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc.. Document filed by Keryx Biopharmaceuticals, Inc..(Gunther, Robert) |
| Filing 3 REQUEST FOR ISSUANCE OF SUMMONS as to Par Pharmaceutical, Inc., re: #1 Complaint,. Document filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Gunther, Robert) |
| Filing 2 CIVIL COVER SHEET filed. (Gunther, Robert) |
| Filing 1 COMPLAINT against PAR Pharmaceutical, Inc.. (Filing Fee $ 400.00, Receipt Number ANYSDC-16953771)Document filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Attachments: #1 Exhibit A - 423 patent, #2 Exhibit B - 191 patent)(Gunther, Robert) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
